Form 4: P3 Health Partners Director Receives RSU Grant

P3 Health Partners Director Gregory N. Kazarian was granted 2,000 restricted stock units, increasing his total beneficial ownership to 218,561 shares.

Summary

• Gregory N. Kazarian, a Director of P3 Health Partners Inc. (PIII), was granted 2,000 shares of Class A Common Stock in the form of Restricted Stock Units (RSUs).
• The grant was made on August 6, 2025, pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan.
• Each RSU represents the right to receive one share of Class A Common Stock.
• The RSUs are scheduled to vest in one year from the grant date.
• Following this transaction, Gregory N. Kazarian beneficially owns a total of 218,561 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: The filing reports a routine insider equity grant, which is generally viewed as a neutral to slightly positive event as it aligns management interests with shareholders. There are no negative implications or significant new financial data to alter overall sentiment.

Positives

• The grant of 2,000 Restricted Stock Units to a Director aligns management's interests with those of shareholders, as the value of the grant is tied to the company's stock performance.
• The transaction is part of a pre-existing incentive award plan, indicating a structured approach to executive compensation.

Future Outlook

The 2,000 Restricted Stock Units granted are scheduled to vest in one year from the grant date, indicating a future increase in the director's vested equity holdings.

Industry Context

Insider equity grants, such as Restricted Stock Units, are a common component of executive and director compensation packages across various industries, particularly in publicly traded companies. These grants are designed to align the interests of company leadership with those of shareholders by tying a portion of their compensation to the company's stock performance.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's financial interests with shareholder value, as the value of the RSUs is directly tied to the company's stock performance.
• Employees: The grant is part of an incentive award plan, which may be indicative of broader compensation strategies that could impact employee morale and retention.

Next Steps

• Vesting of the 2,000 Restricted Stock Units one year from the grant date (approximately August 6, 2026).

Key Dates

Recommendation

This Form 4 filing details a routine insider equity grant as part of an existing compensation plan. It does not contain new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. The transaction is a standard practice for aligning director interests with shareholders.

Keywords

P3 Health Partners, PIII, Form 4, RSU, Restricted Stock Units, Insider Transaction, Director, Equity Grant, Executive Compensation